Nutrient quality
The sugar-cane policosanol amount is appropriate and the pairing fits a cardiovascular purpose. Low CoQ10 potency, an unspecified molecular form, and dry-tablet delivery limit the second active.
| $ 10.41 | ||
| $ 10.41 | ||
Vitacost | $ 10.49 |
The tablet uses sugar-cane policosanol at a meaningful amount and adds CoQ10 as a complementary active. Both weights are stated clearly.
Policosanol lacks octacosanol standardization, leaving its active alcohol profile uncertain. CoQ10 is low, has no identified molecular form, and receives no oil carrier in the dry tablet.
The product fits adults specifically seeking sugar-cane policosanol with a small CoQ10 addition. It should not be selected as a substantial standalone CoQ10 supplement.
The sugar-cane policosanol amount is appropriate and the pairing fits a cardiovascular purpose. Low CoQ10 potency, an unspecified molecular form, and dry-tablet delivery limit the second active.
Active amounts are clearly disclosed and no proprietary blend hides key doses. Daily directions and a complete inactive-ingredient list are not available in the supplied data.
The aggregate satisfaction measure is favorable, with response volume determining how much confidence it deserves. Comment-level evidence is absent, so recurring complaints and purpose fit cannot be verified.
Economical serving value works well for the policosanol component but less well for the undersized CoQ10 addition. The simple pairing remains competitive for users prioritizing sugar-cane policosanol.
| Ingredient | Amount per serving |
|---|---|
Total Carbohydrates | 1 Gram(s) |
Coenzyme Q-10 | 30 mg |
Policosanol (Sugar Cane) | 20 mg |
Sugar cane is the preferred source for the available policosanol evidence, and the disclosed amount matches the collection target. The label does not state octacosanol content, leaving the active fatty-alcohol profile uncertain. Added CoQ10 strengthens the heart-health formulation and helps justify the moderately higher serving cost.
The 30 mg CoQ10 dose is too low for the stated collection goals. Its molecular form is not identified, and the dry tablet lacks an oil base or other stated absorption aid. The low serving cost does not offset the small dose and limited formulation detail.